Introduction
============

The British Society of Echocardiography (BSE) Education Committee has previously published a minimum dataset for a standard adult transthoracic echocardiogram [@bib1]. This Guideline specifically states that the minimum dataset is usually sufficient only when the echocardiographic study is entirely normal. The aim of the BSE Education Committee is to publish a series of appendices to cover specific pathologies supporting this minimum dataset.The intended benefits of such supplementary recommendations are to:Support cardiologists and echocardiographers to develop local protocols and quality control programs for adult transthoracic study.Promote quality by defining a set of descriptive terms and measurements, in conjunction with a systematic approach to performing and reporting a study in specific disease states.Facilitate the accurate comparison of serial echocardiograms performed in patients at the same or different sites.This Guideline gives recommendations for the image and analysis dataset required in patients either being assessed for, or with a known diagnosis of hypertrophic cardiomyopathy (HCM). The views and measurements are supplementary to those outlined in the minimum dataset and are given assuming that a full study will be performed in all patients.When the condition or acoustic windows of the patient prevent the acquisition of one or more components of the supplementary dataset, or when measurements result in misleading information (e.g. off-axis measurements), this should be stated.This document is a guideline for echocardiography in HCM and will be updated in accordance with changes directed by publications or changes in practice ([Table 1](#tbl2){ref-type="table"}).Table 1Additional views and measurements to be obtained in patients with known or suspected hypertrophic cardiomyopathy**View** (modality)**MeasurementExplanatory noteImage**PLAX (2D/MM)IVSdIVSd measure \>3 cm is a key marker of increased risk [@bib2]\
Demonstrate if ASH is present\
Measure RV wall thickness if on axis![](echo-02-G1-i001.jpg)PLAX (2D/MM)LA sizeMeasure LA size (anterior--posterior diameter). LA diameter is one of the criteria used to estimate risk of sudden cardiac death [@bib3]![](echo-02-G1-i002.jpg)PLAX (MM and CFM)MV leaflet tips and AV leaflet tipsDemonstrate if SAM is present on M-Mode and for colour flow turbulence within the LVOT\
Demonstrate if early closure of the AV![](echo-02-G1-i003.jpg)PSAX MV (2D)Frozen 2D image: obtain wall thickness measurements from level of the basal LV. Measure at four points, using clock face references (12, 3, 6, 9 o\'clock)To assess for asymmetric and symmetric segmental LV hypertrophy\
Segmental hypertrophy \>1.5 cm [@bib2] with normal or small LV internal cavity dimensions is strongly suggestive of HCM (in absence of other pathologies such as hypertension)![](echo-02-G1-i004.jpg)PSAX PM (2D)2D frozen image at the mid-LV level. Measure at four points, using clock face references (12, 3, 6, 9 o\'clock)Avoid off-axis measurements, papillary muscle and trabeculations![](echo-02-G1-i005.jpg)PSAX Apex (2D)Apical-level measure at two points (12 and 6 o\'clock)Apical hypertrophy may be present if apical/basal lateral ratio is \>1.5. Consideration should be given to use of LV opacification contrast![](echo-02-G1-i006.jpg)Modified PSAX (2D and PW/CW)RV wall thickness and RVOT forward flow velocitiesModify both the RV inflow and outflow to assess for RVH and RVOT obstruction. RVH present if \>0.5 cm![](echo-02-G1-i007.jpg)Modified A4C (2D)RV wall thicknessIf clear images can be obtained, measure RV wall thickness. Otherwise measurement from PLAX and subcostal views is preferred. RVH present if \>0.5 cm![](echo-02-G1-i008.jpg)A4C and A2C (2D)LA volumeIndex LA volume to BSA [@bib4]![](echo-02-G1-i009.jpg)A4C (CFM)Aetiology and severity of mitral regurgitationIf SAM is present, MR may be eccentric and is usually mid/late systolic![](echo-02-G1-i010.jpg)A4C (PW TDI)Systolic (s\'), early (e\') and atrial (a\') relaxation velocities at anterolateral LV annulusReduction in s\' or e\' velocities below normal range for age and sex [@bib5]\
Assess for elevated LVEDp by measuring E/e\'. Average septal and lateral velocities for e\'. Abnormal if \>10 [@bib4]![](echo-02-G1-i011.jpg)A4C (PW TDI)Systolic (s\'), early (e\') and atrial (a\') relaxation velocities at inferoseptal LV annulusReduction in Sa or Ea velocities below normal range for age and sex [@bib5]\
Assess for elevated LVEDp by measuring E/e\'. Average septal and lateral velocities for e\'. Abnormal if \>10 [@bib4]![](echo-02-G1-i012.jpg)A5C and A3C (CFM)Locate turbulent flow both within the LV cavity and the LVOT![](echo-02-G1-i013.jpg)A5C and A3C (PW/CW)Quantify LVOT/LV intracavity dynamic flow gradientSample PW Doppler throughout the LV cavity, paying particular attention to areas with turbulent flow. HPRF/CW Doppler may be appropriate if aliasing occurs. Take care not to include MR jet in sample volume. A Valsalva manoeuvre should be performed in the sitting and semi-supine position (and then on standing if no gradient is produced) to assess dynamic LVOT gradients. The peak gradient (rest or Valsalva) should be recorded. In addition, exercise stress echocardiography should be considered in patients with LVOT gradients \<50 mmHg at rest (with or without Valsalva) [@bib3]![](echo-02-G1-i014.jpg)A2C (PW TDI)Systolic (s\'), early (e\') and atrial (a\') relaxation velocities at inferior LV annulusReduction in s\' or e\' velocities below normal range for age and sex [@bib5]![](echo-02-G1-i015.jpg)A2C (PW TDI)Systolic (s\'), early (e\') and atrial (a\') relaxation velocities at anterior LV annulusReduction in s\' or e\' velocities below normal range for age and sex [@bib5]![](echo-02-G1-i016.jpg)

[](#tbl1){ref-type="table"} Abbreviations**Views** A2CApical two chamber A4CApical four chamber A5CApical five chamber A3CApical three chamber or apical long axis PLAXParasternal long axis PSAXParasternal short axis SCSubcostal SSNSuprasternal**Modality** CFMColour flow Doppler CWContinuous-wave Doppler PWPulse wave Doppler TDITissue Doppler imaging**Measurement and explanatory text** a\'Lateral and/or septal late annular relaxation velocity AoAorta ASHAsymmetrical septal hypertrophy AVAortic valve BSABody surface area DTDeceleration time e\'Lateral and/or septal early annular relaxation velocity HCMHypertrophic cardiomyopathy HPRFHigh pulse repetition frequency IVCInferior vena cava IVSdInterventricular septal width in diastole LALeft atrium LLPVLeft lower pulmonary vein LPALeft pulmonary artery LUPVLeft upper pulmonary vein LVLeft ventricle LVEDpLeft ventricular end-diastolic pressure LVIDd/sLeft ventricular internal dimension in diastole and systole LVOTLeft ventricular outflow tract LVPWdLeft ventricular posterior wall width in diastole MAPSEMitral annular plane systolic excursion MRMitral regurgitation MVMitral valve PAPulmonary artery PAPPulmonary artery pressure PHTPressure half-time PRPulmonary regurgitation PSPulmonary stenosis PVPulmonary valve RARight atrium RLPVRight lower pulmonary vein RUPVRight upper pulmonary vein RVRight ventricle RVHRight ventricular hypertrophy RVIDdRight ventricular cavity diameter in diastole RWMARegional wall motion abnormality RVOTRight ventricular outflow tract RVOTdRight ventricular outflow tract dimension s\'Lateral and/or septal systolic annular velocity SAMSystolic anterior motion STJSinotubular junction SVolStroke volume TAPSETricuspid annular plane systolic excursion TRTricuspid regurgitation TVTricuspid valve VmaxMaximum velocity VSDVentricular septal defect VTIVelocity time integral
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